- CROI Conference
ALERT: Fraudulent websites and emails offering CROI registration or hotel reservations are circulating, including Converia Travel Some scammers also impersonate CROI personnel; verify email domains carefully
- Conference on Retroviruses and Opportunistic Infections (CROI) 2026 . . .
The CROI 2026 meeting promises to be a vibrant gathering of thought leaders in HIV treatment, prevention, and cure research We're thrilled to amplify the brilliant presenters from our division, each contributing to the advancement of healthcare practices
- CROI 2026: Resources and what to watch - AVAC
CROI 2026: Resources and what to watch Resources and What to Watch February 17, 2026 The annual Conference on Retroviruses and Opportunistic Infections (CROI), taking place February 22–25, 2026, in Denver, Colorado, will once again kick off the year as the premier scientific convening for our field
- CROI 2026 - hepCoalition
The 33rd Conference on Retroviruses and Opportunistic Infections (CROI 2026) will be held in Denver, USA and virtually from 22 to 25 February 2026 CROI 2026 will highlight the latest research in HIV, hepatitis viruses, SARS-CoV-2 (including long COVID), mpox, and their related conditions
- 2025 Conference on Retroviruses and Opportunistic Infections
If you do not have a linked CROI 2025 registration, you need to link your registration by entering your RegID (the 4 digits on the bottom left corner of your badge, or it is on your confirmation email) and the email you used to register for the conference
- CROI Webcasts: CROI 2025
Lishomwa Ndhlovu Weill Cornell Medicine, New York, NY, USA slides video mp3 from CROI 2025 on March 9, 2025 8:30 AM-12:30 PM
- Summary of UCSF and CFAR ARI Partner Abstracts at CROI 2026
CFAR Summary of CROI 2026 Abstracts ORAL PRESENTATIONS SUNDAY – FEBRUARY 22, 2026 Workshop-04 | Clinical Trial Design and Analysis Workshop 2:00 PM - 4:00 PM • Four Seasons Ballroom 1 2:00PM: Clinical Trials in the Post-Lenacapavir Era David V Glidden, PhD MS Monday – February 23, 2026 Oral Abstract Session-01 | Interaction of HIV With Cells and People 10:00 AM - 12:00 PM • Mile High
- Conference on Retroviruses and Opportunistic Infections San Francisco . . .
ViiV HEALTHCARE SHOWCASES LEADERSHIP IN LONG-ACTING INJECTABLES INNOVATION AT CROI 2025 WITH DATA ON THIRD-GENERATION INTEGRASE INHIBITOR (INSTI) AND HIGHLY POTENT CAPSID INHIBITOR AGAINST HIV-1 - (03 12 25)
|